Skip to main content
. 2005 Feb 5;330(7486):293. doi: 10.1136/bmj.38338.674583.AE

Table 1.

Baseline comparison of intervention and control group patients. Values are numbers (percentages) unless stated otherwise

Characteristic Intervention group (n=429) Control group (n=426)
Female 262 (61.1) 272 (63.8)
Mean (SD) age (years) 85.4 (4.0) 85.5 (4.0)
Living alone 263 (61.3) 268 (62.9)
Mean (SD) abbreviated mental test 8.9 (1.6) 8.9 (1.5)
Mean (SD) daily drugs 6.0 (2.7) 5.8 (2.3)
Mean (SD) total drugs 6.4 (2.8) 6.3 (2.5)
Monitored dose system* 81 (19.8) 71 (17.4)
Social class (I, II, IIInm) 170 (42.6) 163 (41.4)
Mean (SD) length of baseline admission (days) 13.6 (14.6) 13.4 (15.3)
Mean (SD) days from recruitment to discharge 1.7 (3.9) 1.8 (7.0)
Baseline diagnosis
Cardiovascular (total): 134 (31.2) 144 (33.8)
Myocardial infarction/angina 57 (13.3) 65 (15.3)
Heart failure 38 (8.9) 34 (8.0)
Musculoskeletal (total): 61 (14.2) 65 (15.3)
Fracture 37 (8.6) 40 (9.4)
Gastrointestinal (total) 47 (11.0) 54 (12.7)
Respiratory (total): 48 (11.2) 49 (11.5)
COPD/asthma 15 (3.5) 13 (3.1)
Lower respiratory tract infection 16 (3.7) 22 (5.2)
Neurological: 40 (9.3) 25 (5.9)
Stroke/transient ischaemic attack 16 (3.7) 14 (3.3)
Senility/dementia 16 (3.7) 6 (1.4)
Genitourinary 17 (4.0) 16 (3.8)
Cancer (total) 15 (3.5) 7 (1.6)
Other or unclassified 67 (15.6) 66 (15.5)

COPD=chronic obstructive pulmonary disease.

*

Monitored dose system data available for only 817 patients (409 intervention and 408 control).

Employment details available for only 793 patients (399 intervention and 394 control).